Trial Profile
Safety and efficacy trial of perampanel as adjunctive therapy in combination with other antiepileptic drugs in patients with uncontrolled focal seizures.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2016
Price :
$35
*
At a glance
- Drugs Perampanel (Primary) ; Carbamazepine; Levetiracetam; Oxcarbazepine
- Indications Partial epilepsies
- Focus Therapeutic Use
- 23 Feb 2016 New trial record